SQSTM1 and fragile X-associated tremor/ataxia syndrome: Compared to controls, FXTAS patients showed a consistent 30% higher accumulation of p62 in all time points of the experiment and a 20% higher accumulation of LC3BII protein levels at 4 h treatment.